{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T11:42:01Z","timestamp":1788090121001,"version":"build-2803163510"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,20]]},"DOI":"10.7759\/cureus.99731","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T01:00:30Z","timestamp":1766278830000},"source":"Crossref","is-referenced-by-count":2,"title":["Unanticipated Residual Gastric Contents in an Appropriately Fasted Pediatric Patient on Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Case Report and Review of Perioperative Considerations"],"prefix":"10.7759","author":[{"given":"Max","family":"Lookabaugh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim M","family":"Strupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2208601","article-title":"Once-weekly semaglutide in adolescents with obesity","volume":"387","author":"Weghuber D","year":"2022","unstructured":"Weghuber D, Barrett T, Barrientos-P\u00e9rez M, et al.. Once-weekly semaglutide in adolescents with obesity. N Engl J Med. 2022, 387:2245-57. 10.1056\/NEJMoa2208601","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-025-04228-1","article-title":"GLP-1 receptor agonists for the treatment of obesity in children and adolescents: a meta-analysis of randomized controlled trials","author":"Romariz LM","year":"2025","unstructured":"Romariz LM, de Melo AA, Finnegan E, Mesquita Y, Janovsky CC. GLP-1 receptor agonists for the treatment of obesity in children and adolescents: a meta-analysis of randomized controlled trials. Pediatr Res. 2025, 10.1038\/s41390-025-04228-1","journal-title":"Pediatr Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000001452","article-title":"Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists task force on preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration","volume":"126","year":"2017","unstructured":"Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration. application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists task force on preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration. Anesthesiology. 2017, 126:376-93. 10.1097\/ALN.0000000000001452","journal-title":"Anesthesiology"},{"key":"ref4","unstructured":"American Society of Anesthesiologists consensus-based guidance on preoperative management of patients (adults and children) on glucagon-like peptide-1 (GLP-1) receptor agonists. (2023). Accessed. September 12, 2025: https:\/\/www.asahq.org\/about-asa\/newsroom\/news-releases\/2023\/06\/american-society-of-anesthesiologists-consensus-based-...."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2024.08.033","article-title":"Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period","volume":"20","author":"Kindel TL","year":"2024","unstructured":"Kindel TL, Wang AY, Wadhwa A, et al.. Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period. Surg Obes Relat Dis. 2024, 20:1183-6. 10.1016\/j.soard.2024.08.033","journal-title":"Surg Obes Relat Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aev113","article-title":"I-AIM framework for point-of-care gastric ultrasound","volume":"116","author":"Perlas A","year":"2016","unstructured":"Perlas A, Van de Putte P, Van Houwe P, Chan VW. I-AIM framework for point-of-care gastric ultrasound. Br J Anaesth. 2016, 116:7-11. 10.1093\/bja\/aev113","journal-title":"Br J Anaesth"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1200101","article-title":"Gut dysmotility in children with neurological impairment: the nutritional management","volume":"14","author":"Corsello A","year":"2023","unstructured":"Corsello A, Scatigno L, Govoni A, Zuccotti G, Gottrand F, Romano C, Verduci E. Gut dysmotility in children with neurological impairment: the nutritional management. Front Neurol. 2023, 14:1200101. 10.3389\/fneur.2023.1200101","journal-title":"Front Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-017-1031-9","article-title":"Point-of-care gastric ultrasound and aspiration risk assessment: a narrative review","volume":"65","author":"Perlas A","year":"2018","unstructured":"Perlas A, Arzola C, Van de Putte P. Point-of-care gastric ultrasound and aspiration risk assessment: a narrative review. Can J Anaesth. 2018, 65:437-48. 10.1007\/s12630-017-1031-9","journal-title":"Can J Anaesth"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2024.0111","article-title":"Glucagon-like peptide-1 receptor agonist use and residual gastric content before anesthesia","volume":"159","author":"Sen S","year":"2024","unstructured":"Sen S, Potnuru PP, Hernandez N, Goehl C, Praestholm C, Sridhar S, Nwokolo OO. Glucagon-like peptide-1 receptor agonist use and residual gastric content before anesthesia. JAMA Surg. 2024, 159:660-7. 10.1001\/jamasurg.2024.0111","journal-title":"JAMA Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-024-02719-z","article-title":"Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study","volume":"71","author":"Wu F","year":"2024","unstructured":"Wu F, Smith MR, Mueller AL, et al.. Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study. Can J Anaesth. 2024, 71:958-66. 10.1007\/s12630-024-02719-z","journal-title":"Can J Anaesth"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000007764","article-title":"Assessment of gastric content using gastric ultrasound in patients on glucagon-like peptide-1 receptor agonists before anesthesia","author":"Pai SL","year":"2025","unstructured":"Pai SL, Nimma SR, Beam WB, et al.. Assessment of gastric content using gastric ultrasound in patients on glucagon-like peptide-1 receptor agonists before anesthesia. Anesth Analg. 2025, 10.1213\/ANE.0000000000007764","journal-title":"Anesth Analg"},{"key":"ref12","article-title":"Delayed gastric emptying in pediatric patients on GLP-1 receptor agonists with standard NPO guidelines: a prospective ultrasound study","author":"O'Brien EM","year":"2025","unstructured":"O'Brien EM, Washburn M, Dumas A, Como N, Kilungya F, Willi SM, Lin EE. Delayed gastric emptying in pediatric patients on GLP-1 receptor agonists with standard NPO guidelines: a prospective ultrasound study. University of Pennsylvania, Philadelphia, PA; 2025. https:\/\/www2.pedsanesthesia.org\/meetings\/2025winter\/guide\/posters\/uploads\/332--YIA-2.pdf."},{"key":"ref13","unstructured":"Are serious anesthesia risks of semaglutide and other GLP-1 agonists under-recognized? Case reports of retained solid gastric contents in patients undergoing anesthesia. (2023). Accessed. 2025: https:\/\/www.apsf.org\/article\/are-serious-anesthesia-risks-of-semaglutide-and-other-glp-1-agonists-under-recognized\/."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1638981","article-title":"GLP-1 receptor agonist increase retained gastric contents on EGD and same-day colonoscopy reduces this risk","volume":"12","author":"Ukwade D","year":"2025","unstructured":"Ukwade D, Hernandez LJ, Modi Z, et al.. GLP-1 receptor agonist increase retained gastric contents on EGD and same-day colonoscopy reduces this risk. Front Med (Lausanne). 2025, 12:1638981. 10.3389\/fmed.2025.1638981","journal-title":"Front Med (Lausanne)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.10.003","article-title":"Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period","volume":"23","author":"Kindel TL","year":"2025","unstructured":"Kindel TL, Wang AY, Wadhwa A, et al.. Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period. Clin Gastroenterol Hepatol. 2025, 23:2083-5. 10.1016\/j.cgh.2024.10.003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13216336","article-title":"A scoping review of GLP-1 receptor agonists: are they associated with increased gastric contents, regurgitation, and aspiration events?","volume":"13","author":"Chang MG","year":"2024","unstructured":"Chang MG, Ripoll JG, Lopez E, Krishnan K, Bittner EA. A scoping review of GLP-1 receptor agonists: are they associated with increased gastric contents, regurgitation, and aspiration events?. J Clin Med. 2024, 13:6336. 10.3390\/jcm13216336","journal-title":"J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/433661-unanticipated-residual-gastric-contents-in-an-appropriately-fasted-pediatric-patient-on-glucagon-like-peptide-1-receptor-agonist-therapy-a-case-report-and-review-of-perioperative-considerations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T01:00:32Z","timestamp":1766278832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/433661-unanticipated-residual-gastric-contents-in-an-appropriately-fasted-pediatric-patient-on-glucagon-like-peptide-1-receptor-agonist-therapy-a-case-report-and-review-of-perioperative-considerations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.99731","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,20]]}}}